Livio Luongo
4Patents
1h-index
7Co-inventors
30Inventor score
Filing activity: Apr 11, 2017 → Dec 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11679087B2 | Use of cannabinoids in the treatment of Angelman syndrome | Human Necessities | 15 | Active |
| US12150927B2 | Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders | Human Necessities | 0 | Active |
| US11752111B2 | Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia | Human Necessities | 0 | Active |
| US10898462B2 | Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.